Inventor
LAUFFENBURGER DOUGLAS A
US13 patents
⚠️ This page may combine multiple inventors who share the name “LAUFFENBURGER DOUGLAS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MASSACHUSETTS INST TECHNOLOGY
11 patentsUS8349311B2Jan 8, 2013
Mutant interleukin-2 (IL-2) polypeptides
MASSACHUSETTS INST TECHNOLOGY40 citations96
US7951360B2May 31, 2011
Mutant interleukin-2 (IL-2) polypeptides
MASSACHUSETTS INST TECHNOLOGY45 citations96
US7569215B2Aug 4, 2009
Mutant interleukin-2 (IL-2) polypeptides
MASSACHUSETTS INST TECHNOLOGY89 citations96
US6946548B2Sep 20, 2005
G-CSF analog compositions and methods
MASSACHUSETTS INST TECHNOLOGY28 citations89
US7371370B2May 13, 2008
Methods of using G-CSF analog compositions
MASSACHUSETTS INST TECHNOLOGY10 citations81
US6790628B2Sep 14, 2004
Method for screening analogs of G-CSF
MASSACHUSETTS INST TECHNOLOGY4 citations71
US7402304B2Jul 22, 2008
Methods of using G-CSF analog compositions
MASSACHUSETTS INST TECHNOLOGY1 citations60
US10928397B2Feb 23, 2021
Methods involving MenaINV in screening for inhibitors of cancer invasion and metastasis
MASSACHUSETTS INST TECHNOLOGY0 citations53
US10028958B2Jul 24, 2018
Methods of treating cancer with a combination of selected MEK1/2 and AXL inhibitors
MASSACHUSETTS INST TECHNOLOGY1 citations42
US10114023B2Oct 30, 2018
Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of menaINV
MASSACHUSETTS INST TECHNOLOGY0 citations41
US11408885B2Aug 9, 2022
Compositions and multiplex assays for characterizing active proteases and their inhibitors
MASSACHUSETTS INST TECHNOLOGY0 citations38